-
Published 9/3/2026
Lees RD, Patel P, Young G, Beck L, Marin AM, Parkinson D, Pele L, Parkes M, Sanderson J, Herbert C, Hullah E, Lamb CA, Mawdsley J, Speight RA. Orofacial granulomatosis associated with Crohn's disease: clinical phenotype and response to biologics and Janus kinase inhibitor therapy in a large multi-center cohort. J Crohns Colitis. 2026 Sep 03; 20(9). PMID: 42768927.
-
Published 7/10/2026
Gerety MK, Charu V, Simmons M, Seewald NJ, Glenn DA, Schaubel DE, Smith AR, Chen D, Laurin LP, Denburg M, Holzman LB, Beck LH, Mariani LH, Zee J. Real-World Long-term Comparisons of Rituximab versus Calcineurin Inhibitors for Membranous Nephropathy in the Cure Glomerulonephropathy Study. Kidney360. 2026 Jul 10. PMID: 42430748.
-
Published 3/27/2026
Al-Rabadi LF, Storey AJ, Abuelsamen T, Takayama S, Walker PD, Nwaduru CE, Kawalit I, Zimmerman M, Hoxha E, Borza DB, Beck L, Larsen CP, Caza TN. Serine protease HTRA1 is a common autoantigen in membranous nephropathy in patients of 80 years and older. Kidney Int. 2026 Jun; 109(6):1318-1323. PMID: 41905594.
-
Published 2/23/2026
Beck LH, Salant DJ. The podocyte slit-diaphragm: target of anti-nephrin antibodies. Curr Opin Nephrol Hypertens. 2026 May 01; 35(3):279-286. PMID: 41733080.
-
Published 11/20/2025
Kim T, Ju W, Surapaneni A, Li Y, Wen D, Trivin-Avillach C, Rosales IA, Beck LH, Nair V, Fermin D, Zee J, Schmidt IM, Srivastava A, Palsson R, Stillman IE, Kretzler M, Coresh J, Waikar SS, Grams ME, Rhee EP. Circulating Testican-2 and MGT5A are Markers of Membranous Nephropathy. Kidney Int Rep. 2026 Feb; 11(2):103695. PMID: 41502806.